Increased incidence of Hodgkin disease in homosexual men with HIV infection

Ann Intern Med. 1992 Aug 15;117(4):309-11. doi: 10.7326/0003-4819-117-4-309.

Abstract

Objective: To evaluate the incidence of Hodgkin disease and non-Hodgkin lymphoma among homosexual men infected with human immunodeficiency virus (HIV).

Design: Cohort study with computer-matched identification of participants with the Northern California Cancer Center registry. Population rate comparisons were made with data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry.

Participants: The 6704 homosexual men in the San Francisco City Clinic Cohort study.

Measurements: Incidence of Hodgkin disease, non-Hodgkin lymphoma, HIV infection, and the acquired immunodeficiency syndrome (AIDS); calculation of sex and age-adjusted standardized morbidity ratios and attributable risk.

Results: Eight cases of Hodgkin disease and 90 cases of non-Hodgkin lymphoma were identified through computer matching among cohort members residing in the San Francisco Bay area from 1978 through 1989. Among the HIV-infected men, the age-adjusted standardized morbidity ratio was 5.0 (95% CI, 2.0 to 10.3) for Hodgkin disease and 37.7 (CI, 30.3 to 46.7) for non-Hodgkin lymphoma. The excess risk attributable to HIV infection was 19.3 cases of Hodgkin disease per 100,000 person-years and 224.9 cases of non-Hodgkin lymphoma per 100,000 person-years.

Conclusion: An excess incidence of Hodgkin disease was found in HIV-infected homosexual men. Additional well-designed epidemiologic studies are needed to determine whether Hodgkin disease should be considered an HIV-related malignancy.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • HIV Infections / complications*
  • Hodgkin Disease / epidemiology*
  • Hodgkin Disease / etiology
  • Homosexuality*
  • Humans
  • Incidence
  • Lymphoma, AIDS-Related / epidemiology
  • Lymphoma, Non-Hodgkin / epidemiology
  • Male
  • Middle Aged
  • Morbidity
  • Prevalence
  • Prospective Studies
  • Risk